Cidara Therapeutics (CDTX) Tops Q1 EPS by 9c

Cidara Therapeutics (NASDAQ: CDTX) reported Q1 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $25.99 million versus the consensus estimate of $16.25 million.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Tech eyes recovery after selloff, Micron to report results - What’s moving markets
• Cerebras Q1 EPS miss sends shares down 9% after-hours